Rates of Alzheimer disease biomarker positivity stratified by by sex and race in a specialty memory clinic

生物标志物 医学 内科学 肿瘤科 疾病 阿尔茨海默病 血液检验 痴呆 队列 癌症 淀粉样蛋白(真菌学) 记忆诊所 考试(生物学)
作者
Anna Hofmann,Madeline Paczynski,Zachary J Posey,Melissa Aldinger,Tammie L.S. Benzinger,John C. Morris,B. Joy Snider,Suzanne E. Schindler
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:21 (S2)
标识
DOI:10.1002/alz70856_105627
摘要

Abstract Background The Washington University Memory Diagnostic Center (MDC) in St. Louis, Missouri, annually sees approximately 4,000 patients with memory and thinking concerns and uses multiple biomarker modalities to assess for AD pathology, including to establish eligibility for anti‐amyloid treatments. We assessed the use of different biomarker modalities over time and the rates of biomarker positivity by sex and racial group. Method Biomarker positivity was based on the clinical interpretation of the Elecsys p ‐tau181/Aβ42 CSF test (Roche), the PrecivityAD and PrecivityAD2 blood tests (C2N Diagnostics), and Florbetaben or Florbetapir amyloid PET scans. Clinical and demographic data were retrospectively collected from electronic health records. Result A total of 970 patients were included who underwent at least one AD biomarker test between June 2021 and December 2024 at the MDC and/or anti‐amyloid treatment initiation. The average patient age was 71.5 ± 9.3 years (mean ± standard deviation), 51% were female, and 93% were White. The numbers of tests performed were as follows: 500 CSF tests, 290 amyloid PET scans, 143 PrecivityAD2 blood tests, and 87 PrecivityAD blood tests (Table 1). 50 patients underwent testing with more than one biomarker modality. The monthly volume of biomarker testing increased from ∼10 patients/month from July 2021‐July 2022 to ∼40 patients/month from July 2023‐July 2024 (Figure 1). Females were more likely than males to be biomarker positive: for CSF tests, 73% females and 65% males were positive, p = 0.041; for amyloid PET, 77% females and 67% males were positive, p = 0.045; for the PrecivityAD2 blood test, 82% females and 63% males were positive, p = 0.010 (Figure 2a). Only 42 individuals undergoing biomarker testing were Black (4%). White individuals were more likely than Black individuals to be biomarker positive on CSF tests (71% White and 35% Black were positive, p = 0.0018); few Black individuals underwent amyloid PET or blood tests (Figure 2b). Conclusion The MDC used a combination of CSF tests, blood tests, and amyloid PET scans to scale up AD biomarker testing over the past three years. Rates of AD biomarker positivity were approximately 70% across all three modalities, with females and White individuals having higher rates of positivity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zero完成签到,获得积分0
刚刚
娓鸢完成签到,获得积分10
刚刚
萤火完成签到 ,获得积分10
刚刚
刚刚
彩色山柏发布了新的文献求助10
1秒前
elf完成签到,获得积分10
1秒前
1秒前
木子完成签到,获得积分10
2秒前
懒洋洋完成签到,获得积分10
2秒前
00完成签到 ,获得积分10
2秒前
赵琪发布了新的文献求助10
2秒前
深情安青的应助被阿白采纳,获得10
2秒前
2秒前
2秒前
胡天硕发布了新的文献求助10
3秒前
3秒前
完美世界的应助被三言两语采纳,获得10
3秒前
啊壕完成签到,获得积分10
3秒前
愉快小凝发布了新的文献求助10
3秒前
慕青的应助被cbw采纳,获得10
4秒前
Xiangping发布了新的文献求助10
4秒前
酷波er的应助被科研小白采纳,获得10
4秒前
Vivi发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
木可可可完成签到,获得积分10
5秒前
颖南婉完成签到,获得积分10
6秒前
小猪哄哄完成签到,获得积分10
6秒前
yinxinyi发布了新的文献求助10
6秒前
华赛发布了新的文献求助10
6秒前
7秒前
小朋友发布了新的文献求助10
7秒前
lolimay完成签到,获得积分10
7秒前
思源的应助被yu采纳,获得10
7秒前
7秒前
8秒前
8秒前
冷酷以山发布了新的文献求助10
8秒前
大个的应助被七七采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482